These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 26825066)
41. Comparative in vitro activity of ciprofloxacin and other antimicrobial agents against aminoglycoside-resistant gram-negative rods and microorganisms isolated from patients with bacteremia. Weinstein MP Chemotherapy; 1986; 32(5):446-52. PubMed ID: 3757586 [TBL] [Abstract][Full Text] [Related]
43. Antimicrobial activity of 12 broad-spectrum agents tested against 270 nosocomial blood stream infection isolates caused by non-enteric gram-negative bacilli: occurrence of resistance, molecular epidemiology, and screening for metallo-enzymes. Jones RN; Pfaller MA; Marshall SA; Hollis RJ; Wilke WW Diagn Microbiol Infect Dis; 1997 Nov; 29(3):187-92. PubMed ID: 9401811 [TBL] [Abstract][Full Text] [Related]
44. Pharmacodynamics of antimicrobials for the empirical treatment of nosocomial pneumonia: a report from the OPTAMA Program. Sun HK; Kuti JL; Nicolau DP Crit Care Med; 2005 Oct; 33(10):2222-7. PubMed ID: 16215374 [TBL] [Abstract][Full Text] [Related]
45. In vitro activity of levofloxacin against recent Gram-negative nosocomial pathogens. Lanzafame A; Bonfiglio G; Santini L; Mattina R Chemotherapy; 2005 Mar; 51(1):44-50. PubMed ID: 15767745 [TBL] [Abstract][Full Text] [Related]
46. Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens. Pollini S; Brunetti J; Sennati S; Rossolini GM; Bracci L; Pini A; Falciani C J Pept Sci; 2017 Apr; 23(4):329-333. PubMed ID: 28176481 [TBL] [Abstract][Full Text] [Related]
47. Nitazoxanide is active against Mycobacterium leprae. Bailey MA; Na H; Duthie MS; Gillis TP; Lahiri R; Parish T PLoS One; 2017; 12(8):e0184107. PubMed ID: 28850614 [TBL] [Abstract][Full Text] [Related]
48. Tigecycline in vitro activity against gram-negative and gram-positive pathogens collected in Italy. Roveta S; Marchese A; Debbia EA Chemotherapy; 2008; 54(1):43-9. PubMed ID: 18073470 [TBL] [Abstract][Full Text] [Related]
49. Analogues of the frog skin peptide alyteserin-2a with enhanced antimicrobial activities against Gram-negative bacteria. Conlon JM; Mechkarska M; Arafat K; Attoub S; Sonnevend A J Pept Sci; 2012 Apr; 18(4):270-5. PubMed ID: 22392897 [TBL] [Abstract][Full Text] [Related]
50. QSAR study on antibacterial activity of sulphonamides and derived Mannich bases. Joshi S; Khosla N Bioorg Med Chem Lett; 2003 Nov; 13(21):3747-51. PubMed ID: 14552772 [TBL] [Abstract][Full Text] [Related]
51. Antimicrobial Resistance in the Intensive Care Unit: A Focus on Gram-Negative Bacterial Infections. MacVane SH J Intensive Care Med; 2017 Jan; 32(1):25-37. PubMed ID: 26772199 [TBL] [Abstract][Full Text] [Related]
52. Activity of imipenem, third-generation cephalosporins, aztreonam and ciprofloxacin against multi-resistant gram-negative bacilli isolated from Chilean hospitals. Zemelman R; Bello H; Dominguez M; Gonzalez G; Mella S; Garcia A J Antimicrob Chemother; 1993 Sep; 32(3):413-9. PubMed ID: 8262863 [TBL] [Abstract][Full Text] [Related]
54. Synthesis and in vitro antibacterial evaluation of novel imidazo[2',1':5,1]-1,2,4-triazolo[4,3-c]-quinazoline derivatives of 5-thioxo-1, 2, 4-triazole, 4-oxothiazolidine, and their open-chain counterparts. Nasr MN; Gineinah MM; El-Bendary ER Arch Pharm (Weinheim); 2003 Dec; 336(12):560-6. PubMed ID: 14677149 [TBL] [Abstract][Full Text] [Related]
55. Synthesis and antibacterial studies of teixobactin analogues with non-isostere substitution of enduracididine. Jin K; Po KHL; Kong WY; Lo CH; Lo CW; Lam HY; Sirinimal A; Reuven JA; Chen S; Li X Bioorg Med Chem; 2018 Mar; 26(5):1062-1068. PubMed ID: 29398444 [TBL] [Abstract][Full Text] [Related]
56. Design, synthesis and biological evaluation of ciprofloxacin tethered bis-1,2,3-triazole conjugates as potent antibacterial agents. Kant R; Singh V; Nath G; Awasthi SK; Agarwal A Eur J Med Chem; 2016 Nov; 124():218-228. PubMed ID: 27592391 [TBL] [Abstract][Full Text] [Related]
58. Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis. Gatadi S; Gour J; Shukla M; Kaul G; Dasgupta A; Madhavi YV; Chopra S; Nanduri S Eur J Med Chem; 2019 Aug; 175():287-308. PubMed ID: 31096152 [TBL] [Abstract][Full Text] [Related]
59. Synthesis and biological evaluation of some 2,4,5-trisubstituted thiazole derivatives as potential antimicrobial and anticancer agents. Al-Saadi MS; Faidallah HM; Rostom SA Arch Pharm (Weinheim); 2008 Jul; 341(7):424-34. PubMed ID: 18574850 [TBL] [Abstract][Full Text] [Related]
60. Increasing the Antimicrobial Activity of Nisin-Based Lantibiotics against Gram-Negative Pathogens. Li Q; Montalban-Lopez M; Kuipers OP Appl Environ Microbiol; 2018 Jun; 84(12):. PubMed ID: 29625984 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]